Abstract
Purpose: We studied the effect of adenovirus-mediated p53 gene transfer on the injured rat carotid artery to determine its ability to decrease the formation of neointima. Methods: In vivo gene transfer was used in isolated segments of balloon-injured rat carotid arteries. Genetically modified adenovirus containing the gene encoding for wild-type p53 (AdWTp53) was applied in three concentrations: 8 × 10 10, 1.6 × 10 10, and 8 × 10 9 pfu/mL. Control rats received either adenovirus null (AdNull), 8 × 10 10 pfu/mL, or Medium-199 solution (vehicle). Expression of p53 was determined 4 days after gene transfer by Western blotting. Neointimal formation was assessed after 14 days by harvesting carotid arteries and determining the intima/media (I/M) ratio based on cross-sectional area measurement. Simultaneously, immunohistochemistry was done to detect the presence of p53 on smooth muscle cell nuclei. Results: P53 expression was confirmed by Western blotting. There was a significant reduction in neointimal formation on all treated animals compared with controls. The highest dose of AdWTp53 (8 × 10 10 pfu/mL) resulted in a near-total arrest of neointimal formation (I/M = 0.09 ± 0.03, mean ± SEM) with P < .0001 versus vehicle (I/M = 2.23 ± 0.15) or AdNull (I/M = 2.12 ± .12). The intermediate dose of AdWTp53 (1.6 × 10 10 pfu/mL) resulted in an I/M value of 1.04 ± 0.18, with P < .001 versus vehicle and P = .001 versus AdNull. The lowest dose (8 × 10 9 pfu/mL) resulted in an I/M value of 1.12 ± 0.18, with P < .001 versus vehicle and P < .002 versus AdNull. The immunohistochemistry was positive for the presence of p53 in rats infected with AdWTp53. Conclusions: Adenovirus-mediated gene transfer of p53 protein significantly decreases the formation of neointima in the rat carotid injury model. This may represent a potential therapy for restenosis in humans. (J Vasc Surg 1999;29:360-9)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.